Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Cancer Pain 2Solid Tumor, Adult 1Medication Adherence 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Colonic Neoplasms 1

Interventions

Morphine 15Oxycodone 13Fentanyl 9nabiximols 5Methadone 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Hydromorphone 3Transcranial Direct Current Stimulation 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Buprenorphine 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1naloxegol 1incobotulinumtoxinA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cancer Pain × Pharmaceutical Services × Clear all
NCT03439904 2019-01-15

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

Zhejiang Cancer Hospital

Phase NA Unknown
200 enrolled

Cancer Pain

NCT03455023 2019-01-15

Individualized Pharmaceutical-care for Inpatients With Cancer Pain

Zhejiang Cancer Hospital

Phase NA Unknown
500 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡